Crump CE, Earp JA, Kozma CM, Hertz-Picciotto I Effect of organization-level variables on differential employee participation in 10 federal worksite health promotion programs. Health Educ Q. 1996 May;23(2):204-23.
Glasgow RE, McCaul KD, Fisher KJ Participation in worksite health promotion: a critique of the literature and recommendations for future practice. Health Educ Q. 1993 Fall;20(3):391-408. Review.
Grosch JW, Alterman T, Petersen MR, Murphy LR Worksite health promotion programs in the U.S.: factors associated with availability and participation. Am J Health Promot. 1998 Sep-Oct;13(1):36-45.
Lewis RJ, Huebner WW, Yarborough CM 3rd Characteristics of participants and nonparticipants in worksite health promotion. Am J Health Promot. 1996 Nov-Dec;11(2):99-106.
Pelletier KR A review and analysis of the clinical- and cost-effectiveness studies of comprehensive health promotion and disease management programs at the worksite: 1998-2000 update. Am J Health Promot. 2001 Nov-Dec;16(2):107-16. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
